Xiaochun Ni
Impact in
- Aging top 5%
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Oncology 18
- Cancer Cells and Metastasis 6
Xiaochun Ni
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Aging 41
- Hepatology 140
- Oncology 385
- Cancer Research 180
- Physiology 51
Countries citing papers authored by Xiaochun Ni
This map shows the geographic impact of Xiaochun Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochun Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochun Ni more than expected).
Fields of papers citing papers by Xiaochun Ni
This network shows the impact of papers produced by Xiaochun Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochun Ni. The network helps show where Xiaochun Ni may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaochun Ni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 6 | |
| 2 | 2021 | 6 | |
| 3 | 2021 | 12 | |
| 4 | 2020 | 14 | |
| 5 | 2019 | 20 | |
| 6 | 2019 | 7 | |
| 7 | 2019 | 20 | |
| 8 | Interaction between CD133 and PI3K-p85 promotes chemoresistance in gastric cancer cells. | 2018 | 21 |
| 9 | 2017 | 15 | |
| 10 | 2016 | 14 | |
| 11 | 2016 | 63 | |
| 12 | 2016 | 59 | |
| 13 | 2016 | 18 | |
| 14 | 2015 | 18 | |
| 15 | 2015 | 49 | |
| 16 | 2014 | 28 | |
| 17 | 2014 | 45 | |
| 18 | 2012 | 38 | |
| 19 | 2012 | 44 | |
| 20 | 2010 | 32 |
About Xiaochun Ni
Xiaochun Ni is a scholar working on Hepatology, Oncology, Aging, Cancer Research and Gastroenterology, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Cells and Metastasis (6 papers), Cancer, Lipids, and Metabolism (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Immune Cell Function and Interaction (5 papers), Metastasis and carcinoma case studies (4 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Aging (41 citations), Hepatology (140 citations), Oncology (385 citations), Cancer Research (180 citations) and Physiology (51 citations). Xiaochun Ni has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Jugang Wu, Jiwei Yu, Yong Yi, Norbert Perrimon, Jian Zhou, Xiaoyan Cai, Jiaxing Wang, Yi‐Peng Fu, Jia Fan and Shuang–Jian Qiu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Medicine, Cell Reports, Genetics and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.